Biomarkers for prediction of skeletal disease progression in mucopolysaccharidosis type I

BACKGROUND: Orthopedic disease progresses in mucopolysaccharidosis type I (MPS I), even with approved therapies and remains a major factor in persistent suffering and disability. Novel therapies and accurate predictors of response are needed. The primary objective of this study was to identify surro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lund, Troy C., Doherty, Terence M., Eisengart, Julie B., Freese, Rebecca L., Rudser, Kyle D., Fung, Ellen B., Miller, Bradley S., White, Klane K., Orchard, Paul J., Whitley, Chester B., Polgreen, Lynda E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932872/
https://www.ncbi.nlm.nih.gov/pubmed/33728251
http://dx.doi.org/10.1002/jmd2.12190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932872/
https://www.ncbi.nlm.nih.gov/pubmed/33728251
http://dx.doi.org/10.1002/jmd2.12190

Ejemplares similares